[{"Assets_0_Q3_USD":197064000.0,"CommonStockSharesOutstanding_0_Q3_shares":32309700.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":8461000.0,"NetIncomeLoss_1_Q3_USD":-20289000.0,"NetIncomeLoss_3_Q3_USD":-65757000.0,"StockholdersEquity_0_Q3_USD":65588000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":2094000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":5611000.0,"Ticker":"VYGR","CIK":"1640266","name":"VOYAGER THERAPEUTICS, INC.","OfficialName":"Voyager Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"363614047.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]